Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation

Channabasavaiah B. Gurumurthy(Nebraska Medical Center), Aidan R. O’Brien(Australian National University), Rolen M. Quadros(University of Nebraska Medical Center), John H. Adams(Texas A&M University), Pilar Alcaide(Tufts University), Shinya Ayabe(RIKEN BioResource Research Center), Johnathan Ballard(Texas A&M University), Surinder K. Batra(University of Nebraska Medical Center), Marie‐Claude Beauchamp(McGill University Health Centre), Kathleen A. Becker(Maine Medical Center Research Institute), Guillaume Bernas(Centre Hospitalier de l’Université de Montréal), David Brough(Manchester Academic Health Science Centre), Francisco J. Carrillo‐Salinas(Tufts University), Wesley Chan(McGill University Health Centre), Hanying Chen(Indiana University – Purdue University Indianapolis), Ruby Dawson(South Australian Health and Medical Research Institute), Victoria DeMambro(Maine Medical Center Research Institute), Jinke D’Hont(Ghent University), Katharine M. Dibb(Manchester Academic Health Science Centre), James D. Eudy(High Throughput Biology (United States)), Lin Gan(University of Rochester Medical Center), Jing Gao(Australian National University), Amy Gonzales(Texas A&M University), Anyonya R. Guntur(Maine Medical Center Research Institute), Huiping Guo(Texas A&M University), Donald W. Harms(University of Nebraska Medical Center), Anne Harrington(Maine Medical Center Research Institute), Kathryn E. Hentges(Manchester Academic Health Science Centre), Neil Humphreys(University of Manchester), Shiho Imai(Tokai University), Hideshi Ishii(The University of Osaka), Mizuho Iwama(RIKEN BioResource Research Center), Eric Jonasch(The University of Texas MD Anderson Cancer Center), Michelle Karolak(Maine Medical Center Research Institute), Bernard Keavney(Manchester Academic Health Science Centre), Nay-Chi Khin(Australian National University), Masamitsu Konno(The University of Osaka), Yuko Kotani(The University of Osaka), Yayoi Kunihiro(The University of Osaka), Imayavaramban Lakshmanan(University of Nebraska Medical Center), Catherine Larochelle(Centre Hospitalier de l’Université de Montréal), Catherine B. Lawrence(Manchester Academic Health Science Centre), Lin Li(Maine Medical Center Research Institute), Volkhard Lindner(Maine Medical Center Research Institute), Xian-De Liu(The University of Texas MD Anderson Cancer Center), Gloria López‐Castejón(University of Manchester), Andrew Loudon(University of Manchester), Jenna Lowe(Australian National University), Loydie A. Jerome‐Majewska(McGill University Health Centre), Taiji Matsusaka(Tokai University), Hiromi Miura(Tokai University), Yoshiki Miyasaka(The University of Osaka), Benjamin Morpurgo(Texas A&M University), Katherine J. Motyl(Maine Medical Center Research Institute), Yo-ichi Nabeshima(Foundation for Biomedical Research and Innovation), Koji Nakade(RIKEN BioResource Research Center), Toshiaki Nakashiba(RIKEN BioResource Research Center), Ken‐ichi Nakashima(RIKEN BioResource Research Center), Yuichi Obata(RIKEN BioResource Research Center), Sanae Ogiwara(Tokai University), Mariette Ouellet(Centre Hospitalier de l’Université de Montréal), Leif Oxburgh(Maine Medical Center Research Institute), Sandra Piltz(South Australian Health and Medical Research Institute), Ilka Pinz(Maine Medical Center Research Institute), Moorthy P. Ponnusamy(University of Nebraska Medical Center), David Ray(University of Oxford), Ronald Redder(High Throughput Biology (United States)), Clifford J. Rosen(Maine Medical Center Research Institute), Nikki Ross(Australian National University), Mark Ruhe(University of California, Davis), Larisa Ryzhova(Maine Medical Center Research Institute), Ane Salvador(Tufts University), Sabrina Alam(McGill University Health Centre), Radislav Sedláček(Czech Academy of Sciences, Institute of Molecular Genetics), Karan Sharma(Marian University - Indiana), Chad Smith(The University of Texas MD Anderson Cancer Center), Katrien Staes(Ghent University), Lora Starrs(Australian National University), Fumihiro Sugiyama(University of Tsukuba), Satoru Takahashi(University of Tsukuba), Tomohiro Tanaka(Nagoya City University), Andrew W. Trafford(Manchester Academic Health Science Centre), Yoshihiro Uno(The University of Osaka), Leen Vanhoutte(Ghent University), Frederique Vanrockeghem(Ghent University), Brandon Willis(University of California, Davis), Christian S. Wright(Indiana University Indianapolis), Yuko Yamauchi(The University of Osaka), Xin Yi(Indiana University Indianapolis), Kazuto Yoshimi(The University of Osaka), Xuesong Zhang(The University of Texas MD Anderson Cancer Center), Yingxin Zhang(The University of Texas Southwestern Medical Center), Masato Ohtsuka(Tokai University), Satyabrata Das(University of Minnesota), Daniel J. Garry(University of Minnesota), Tino Hochepied(Ghent University), Paul Q. Thomas(South Australian Health and Medical Research Institute), Jan Parker‐Thornburg(The University of Texas MD Anderson Cancer Center), Antony Adamson(University of Manchester), Atsushi Yoshiki(RIKEN BioResource Research Center), Jean-Francois Schmouth(Centre Hospitalier de l’Université de Montréal), Andrei Golovko(Texas A&M University), William R. Thompson(Indiana University Indianapolis), K. C. Kent Lloyd(University of California, Davis), Joshua A. Wood(University of California, Davis), Mitra Cowan(McGill University), Tomoji Mashimo(The University of Osaka), Seiya Mizuno(University of Tsukuba), Hao Zhu(The University of Texas Southwestern Medical Center), Petr Kašpárek(Czech Academy of Sciences, Institute of Molecular Genetics), Lucy Liaw(Maine Medical Center Research Institute), Joseph M. Miano(University of Rochester Medical Center), Gaétan Burgio(Australian National University)
Genome biology
August 25, 2019
Cited by 108Open Access
Full Text

Abstract

BACKGROUND: CRISPR-Cas9 gene-editing technology has facilitated the generation of knockout mice, providing an alternative to cumbersome and time-consuming traditional embryonic stem cell-based methods. An earlier study reported up to 16% efficiency in generating conditional knockout (cKO or floxed) alleles by microinjection of 2 single guide RNAs (sgRNA) and 2 single-stranded oligonucleotides as donors (referred herein as "two-donor floxing" method). RESULTS: We re-evaluate the two-donor method from a consortium of 20 laboratories across the world. The dataset constitutes 56 genetic loci, 17,887 zygotes, and 1718 live-born mice, of which only 15 (0.87%) mice contain cKO alleles. We subject the dataset to statistical analyses and a machine learning algorithm, which reveals that none of the factors analyzed was predictive for the success of this method. We test some of the newer methods that use one-donor DNA on 18 loci for which the two-donor approach failed to produce cKO alleles. We find that the one-donor methods are 10- to 20-fold more efficient than the two-donor approach. CONCLUSION: We propose that the two-donor method lacks efficiency because it relies on two simultaneous recombination events in cis, an outcome that is dwarfed by pervasive accompanying undesired editing events. The methods that use one-donor DNA are fairly efficient as they rely on only one recombination event, and the probability of correct insertion of the donor cassette without unanticipated mutational events is much higher. Therefore, one-donor methods offer higher efficiencies for the routine generation of cKO animal models.


Related Papers

No related papers found

Powered by citation graph analysis